Literature DB >> 24185320

Endrin induced alterations in bound carbohydrates in rat serum.

R L Coleman1.   

Abstract

Endrin (1 mg per kg body weight) was daily administered intraperitoneally to rats which were sacrificed in groups of 10 after 5, 12 and 19 days and analyses of blood serums were conpared to appropriate controls. No alterations were found in the concentrations of general serum protein or paper electrophoretically separated serum lipoproteins, albumin, alpha1, alpha2, beta or gamma globulins. Protein bound sialic acid and methyl pentose had increased by the 5th day, remained elevated through the 12th day and appeared to be decreasing back toward control values by the 19th day although these values were still above normal. Bound hexose demonstrated no changes for the first 12 days but had increased significantly by 19 days. Bound hexosamine was significantly decreased by the end of 5 days and remained at this depressed level for the 19 days.

Entities:  

Year:  1968        PMID: 24185320     DOI: 10.1007/BF01558351

Source DB:  PubMed          Journal:  Bull Environ Contam Toxicol        ISSN: 0007-4861            Impact factor:   2.151


  5 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Comparison of continuous and strip paper electrophoresis technics for study of serum glycoproteins.

Authors:  C CAHILL; C L SHETLAR; M R SHETLAR; G STIDWORTHY
Journal:  Proc Soc Exp Biol Med       Date:  1956-10

3.  Determination of serum polysaccharides by the tryptophane reaction.

Authors:  M R SHETLAR; J V FOSTER; M R EVERETT
Journal:  Proc Soc Exp Biol Med       Date:  1948-02

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 5.  Endrin: a review.

Authors:  W L Sowell; C H Lawrence; R L Coleman
Journal:  J Okla State Med Assoc       Date:  1968-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.